Literature DB >> 17336877

Reentry and atrial fibrillation.

Felipe Atienza1, José Jalife.   

Abstract

The mechanisms of human atrial fibrillation (AF) are poorly understood. Experimental studies have demonstrated that cholinergic AF in the sheep heart is maintained by high-frequency reentrant sources (drivers) that result in a consistent left-to-right frequency gradient. More recently, clinical studies have confirmed the existence of a hierarchical organization in the rate of activation of different regions in the atria of patients with paroxysmal and chronic AF. Although maximal dominant-frequency sites were found to play a crucial role in the maintenance of AF in some patients, whether AF drivers in humans are focal or reentrant and whether changes in driver activity alter spatial frequency gradients are unclear. To test the hypothesis that localized functional reentry maintains AF in humans, we determined the effects of adenosine infusion on local dominant frequency at different sites of both atria. In patients with paroxysmal AF, adenosine infusion increases local dominant frequencies, particularly at the pulmonary vein-left atrial junction region, amplifying a left-to-right frequency gradient. In patients with chronic AF, dominant frequency is significantly higher than in patients with paroxysmal AF in all atrial regions surveyed, with the highest adenosine increase of frequencies outside the pulmonary vein region. Adenosine-induced driver acceleration is strongly suggestive of a reentrant mechanism in both groups of AF patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17336877     DOI: 10.1016/j.hrthm.2006.12.004

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  11 in total

Review 1.  Interdependent Relationship Between Atrial Fibrillation and Sinus Rhythm at the Hypothetical Interface of Atrial Fibrillation, Autonomic Tone, Sinoatrial Node and Inflammation : Analytical Review, Reconsiderations, Speculations and New Insights.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 2.  Review of Dominant Frequency Analysis in Atrial Fibrillation.

Authors:  Rakesh Latchamsetty; Abraham G Kocheril
Journal:  J Atr Fibrillation       Date:  2009-10-01

Review 3.  Genetics of atrial fibrillation: implications for future research directions and personalized medicine.

Authors:  Steven A Lubitz; Cevher Ozcan; Jared W Magnani; Stefan Kääb; Emelia J Benjamin; Patrick T Ellinor
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06

Review 4.  Global Substrate Mapping and Targeted Ablation with Novel Gold-tip Catheter in De Novo Persistent AF.

Authors:  Michael Tb Pope; Timothy R Betts
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

5.  Noninvasive Estimation of Epicardial Dominant High-Frequency Regions During Atrial Fibrillation.

Authors:  Jorge Pedrón-Torrecilla; Miguel Rodrigo; Andreu M Climent; Alejandro Liberos; Esther Pérez-David; Javier Bermejo; Ángel Arenal; José Millet; Francisco Fernández-Avilés; Omer Berenfeld; Felipe Atienza; María S Guillem
Journal:  J Cardiovasc Electrophysiol       Date:  2016-02-26

6.  Reentry in an accessory atrioventricular pathway as a trigger for atrial fibrillation initiation in manifest Wolff-Parkinson-White syndrome: a matter of reflection?

Authors:  Jonas H Schwieler; Sharon Zlochiver; Sandeep V Pandit; Omer Berenfeld; José Jalife; Lennart Bergfeldt
Journal:  Heart Rhythm       Date:  2008-08-15       Impact factor: 6.343

7.  On the mechanisms of arrhythmias in the myocardium of mXinalpha-deficient murine left atrial-pulmonary veins.

Authors:  Yu-Jun Lai; Eagle Yi-Kung Huang; Hung-I Yeh; Yen-Lin Chen; Jim Jung-Ching Lin; Cheng-I Lin
Journal:  Life Sci       Date:  2008-07-01       Impact factor: 5.037

8.  Coffee, caffeine, and risk of hospitalization for arrhythmias.

Authors:  Arthur L Klatsky; Amatul S Hasan; Mary Anne Armstrong; Natalia Udaltsova; Cynthia Morton
Journal:  Perm J       Date:  2011

9.  Atrial Fibrillation (Part 1): Pathophysiology, Risk Factors, and Therapeutic Basis.

Authors:  Fatima Dumas Cintra; Marcio Jansen de Oliveira Figueiredo
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

10.  The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation.

Authors:  Catalina Tobón; Laura C Palacio; Bojjibabu Chidipi; Diana P Slough; Thanh Tran; Nhi Tran; Michelle Reiser; Yu-Shan Lin; Bengt Herweg; Dany Sayad; Javier Saiz; Sami Noujaim
Journal:  Front Pharmacol       Date:  2019-11-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.